title: Autonomic dysfunction as a delayed sequelae of acute ethylene glycol ingestion : a case report and review of the literature.
abstract: Ethylene glycol poisoning is a common form of poisoning worldwide. The clinical course of ethylene glycol poisoning usually follows a three-stage progression, although these stages may overlap. A fourth stage of delayed neurological dysfunction consisting of cranial neuropathies has been suggested in several case reports. We describe a patient with unique findings of postural hypotension and gastroparesis following ethylene glycol toxicity with the additional uncommon features of albuminocytologic dissociation and increased intracranial pressure with papilledema. In addition, we provide a review of the literature on delayed neurological manifestations in ethylene glycol toxicity and further elucidate a description of a fourth stage of delayed neurological dysfunction following ethylene glycol poisoning.
authors.affiliation: Department of Medicine, Division of Nephrology and Hypertension, Nassau University Medical Center, NY 11554, USA. drshakeel99@yahoo.com
authors.forename: Sayed S
authors.initials: SS
authors.lastname: Rahman
authors.forename: Satish
authors.initials: S
authors.lastname: Kadakia
authors.forename: Leah
authors.initials: L
authors.lastname: Balsam
authors.forename: Sofia
authors.initials: S
authors.lastname: Rubinstein
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced*; D019855:Ethylene Glycol / Q000506:poisoning*; D006801:Humans; D008297:Male
chemical_list: D019855:Ethylene Glycol
references.citation: Can J Neurol Sci. 1986 Nov;13(4):340-1
references.pmid: 3779535
references.citation: Lancet. 2002 Feb 2;359(9304):444-5
references.pmid: 11844546
references.citation: Am J Kidney Dis. 2009 Jun;53(6):1091-7
references.pmid: 19272685
references.citation: J Med Case Rep. 2010 Jul 21;4:220
references.pmid: 20663174
references.citation: Am J Emerg Med. 2004 Sep;22(5):335-404
references.pmid: 15490384
references.citation: Am J Med. 1989 Jul;87(1):91-2
references.pmid: 2741987
references.citation: Arch Neurol. 1981 Nov;38(11):724-6
references.pmid: 7305705
references.citation: Przegl Lek. 1996;53(3):190-3
references.pmid: 8754382
references.citation: Clin Pharmacol Ther. 2007 Jan;81(1):114-21
references.pmid: 17186009
references.citation: Clin Chem. 1998 Jan;44(1):168-77
references.pmid: 9550575
references.citation: J Neurol Neurosurg Psychiatry. 1997 Aug;63(2):261
references.pmid: 9285476
references.citation: Clin Toxicol (Phila). 2006;44(3):315-8
references.pmid: 16749551
references.citation: Arch Neurol. 1982 Nov;39(11):739-40
references.pmid: 7126009
references.citation: Neurology. 2002 Dec 10;59(11):1809-10
references.pmid: 12473781
references.citation: Clin J Am Soc Nephrol. 2008 Jan;3(1):208-25
references.pmid: 18045860
references.citation: West J Med. 1986 Feb;144(2):225-8
references.pmid: 3953092
references.citation: Nefrologia. 2006;26(6):738-40
references.pmid: 17227253
references.citation: Clin Pharmacol Ther. 1997 Jun;61(6):692-9
references.pmid: 9209253
references.citation: Lancet. 2001 Oct 13;358(9289):1236
references.pmid: 11675063
references.citation: Semin Ophthalmol. 2004 Sep-Dec;19(3-4):72-4
references.pmid: 15590539
references.citation: N Y State J Med. 1987 Mar;87(3):179-80
references.pmid: 3472114
references.citation: Ann Emerg Med. 1991 Feb;20(2):208-10
references.pmid: 1996809
references.citation: Presse Med. 1997 May 31;26(18):856
references.pmid: 9207886
references.citation: J Toxicol Clin Toxicol. 2000;38(4):445-51
references.pmid: 10930063
references.citation: N Engl J Med. 1979 Sep 20;301(12):650-7
references.pmid: 471004
references.citation: Chudoku Kenkyu. 2004 Oct;17(4):365-70
references.pmid: 15678931